港股異動丨九毛九(09922.HK)漲7%盤中破頂 市值逼近300億港元
格隆匯12月10日丨九毛九(09922.HK)大幅拉昇至7%,盤中高見20.45港元創下新高價,暫成交1.82億港元,總市值292.8億港元。大和表示,指首次覆蓋中國領先中菜餐廳品牌營運商—九毛九,給予買入投資評級,目標價為23港元。受到其標準化商業模式、最低供應鏈要求及充裕資本帶動下,九毛九將加快其餐廳擴張計劃,尤其是太二酸菜魚,以在2019至2022年間實現強勁盈利增長。公司管理層曾預計太二品牌今年新開店數有望達到100家,明年新開店數約為100-120家。同時,9月和10月同店銷售額穩步恢復。此外,慫重慶火鍋廠10月經營表現較好,品牌模型仍在不斷完善。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.